Lipid nanoparticles address key drug delivery challenges, including immune evasion, toxicity, and regulatory approval.
Cardiovascular diseases (CVD) are the leading cause of morbidity and mortality worldwide, posing a major challenge to health systems. There are a variety of ...
RenovoRx, Inc., which is developing targeted oncology therapies and commercializing its FDA-cleared RenovoCath drug-delivery devi ...
Peter Abbink, PhD, a Pace® Life Sciences expert, will serve as roundtable facilitator for the "Strategies for Targeted Drug ...
Researchers have developed dual-ligand micelles that can selectively direct drugs to inflamed kidneys by targeting both organ-specific and injury-specific markers. In mouse models of acute kidney ...
Physicians and scientists from the UCLA Health Jonsson Comprehensive Cancer Center will present new research at the American Association for Cancer Research (AACR) Annual Meeting, highlighting ...
The human brain comprises billions of neurons, synapses, and cell types, making it one of the universe’s most intricate and dynamic structures. However, the complexity and sensitivity of the brain can ...
A new avenue for targeted drug delivery has been proposed by researchers from The Grainger College of Engineering at the University of Illinois Urbana-Champaign. Their findings, published in Materials ...
Fabricated with a gel side for carrying drugs and a magnetic side for steering, these microrobots can navigate complex biological environments like intestines. Microrobots formed in droplets could ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results